In-depth analysis of proteomic and genomic fluctuations during the time course of human embryonic stem cells directed differentiation into beta cells
- PMID: 35094488
- DOI: 10.1002/pmic.202100265
In-depth analysis of proteomic and genomic fluctuations during the time course of human embryonic stem cells directed differentiation into beta cells
Abstract
Pluripotent stem cells (PSC) endocrine differentiation at a large scale allows sampling of transcriptome and proteome with phosphoproteome (proteoform) at specific time points. We describe the dynamic time course of changes in cells undergoing directed beta-cell differentiation and show target proteins or previously unknown phosphorylation of critical proteins in pancreas development, NKX6-1, and Chromogranin A (CHGA). We describe fluctuations in the correlation between gene expression, protein abundance, and phosphorylation, following differentiation protocol perturbations at all stages to identify proteoform profiles. Our modeling recognizes outliers on a phenomic landscape of endocrine differentiation, and we describe new biological pathways involved. We have validated our proteomic data by analyzing independent single-cell RNAseq datasets for in-vitro pancreatic islet production and corroborated our findings for several proteins suggestive as targets for future research. The single-cell analysis combined with proteoform data places new protein targets within the specific time point and at the specific pancreatic lineage of differentiating stem cells. We suggest that non-correlating proteins abundances or new phosphorylation motifs of NKX6.1 and CHGA point to new signaling pathways that may play an essential role in beta-cell development. We present our findings for the research community's use to improve endocrine differentiation protocols and developmental studies.
Keywords: NKX6-1, pancreas; beta cell (β-cell), cell signaling, chromogranin, insulin, integrin, laminin; mass spectrometry (MS), multiomics, nano LC-MS/MS; pancreatic islet, phosphoproteomics, phosphorylation, protein dynamic, proteomics, signaling networks, single-cell RNA sequencing, stem cells, systems biology, Type 1 diabetes, Type 2 diabetes.
© 2022 Wiley-VCH GmbH.
References
REFERENCES
-
- Daneman, D. (2006). Type 1 diabetes. The Lancet, 367(9513), 847-858. https://doi.org/10.1016/S0140-6736(06)68341-4
-
- Defronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W H., Holst, J. J., Hu, F. B., Kahn, C. R, Raz, I., Shulman, G. I., Simonson, D. C., Testa, M. A., & Weiss, R. (2015). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1, 15019. https://doi.org/10.1038/nrdp.2015.19.
-
- Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014). Generation of functional human pancreatic beta cells in vitro. Cell, 159(2), 428-439. https://doi.org/10.1016/j.cell.2014.09.040
-
- Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., Yang, Y. H. C., Johnson, J. D., & Kieffer, T. J. (2014). Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 32(11), 1121-1133. https://doi.org/10.1038/nbt.3033
-
- Russ, H. A., Parent, A. V., Ringler, J. J., Hennings, T. G., Nair, G. G., Shveygert, M., Guo, T., Puri, S., Haataja, L., Cirulli, V., Blelloch, R., Szot, G. L., Arvan, P., & Hebrok, M. (2015). Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO Journal, 34(13), 1759-1772. https://doi.org/10.15252/embj.201591058
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
